Sex specific efficacy and safety outcomes in operable stage III non-small cell lung cancer (NSCLC): Pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14

被引：0
|
作者：
Frehner, L. [1 ]
Schaer, S. [2 ]
Hayoz, S. [2 ]
Guckenberger, M. [3 ]
Finazzi, T. [4 ]
Mark, M. T. [5 ]
Addeo, A. [6 ]
Mauti, L. A. [7 ]
Betticher, D. C. [8 ]
Stupp, R. [9 ]
Curioni-Fontecedro, A. [10 ]
Peters, S. [11 ]
Frueh, M. [12 ]
Rothschild, S. I. [13 ,14 ]
Pless, M.
Koenig, D. [15 ]
Schmitt-Opitz, I. [16 ]
Ris, H-B. [17 ]
Ozdemir, B. C. [1 ]
Schmid, S. [1 ]
机构：
[1] Univ Bern, Univ Hosp Bern, Inselspital, Dept Med Oncol, Bern, Switzerland
[2] Swiss Grp Clin Canc Res SAKK Competence Ctr, Stat, Bern, Switzerland
[3] Univ Zurich, Univ Zurich Hosp, Dept Radiat Oncol, Zurich, Switzerland
[4] Univ Hosp Basel, Clin Radiotherapy & Radiat Oncol, Basel, Switzerland
[5] Cantonal Hosp Graubuenden, Div Hematol Oncol, Chur, Switzerland
[6] Univ Hosp Geneva, Dept Oncol, Geneva, Switzerland
[7] Kantonsspital Winterthur, Dept Med Oncol, Winterthur, Switzerland
[8] Univ Fribourg, Cantonal Hosp Fribourg, Clin Oncol, Villars Sur Glane, Switzerland
[9] Northwestern Univ, Feinberg Sch Med, Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[10] Univ Fribourg, Cantonal Hosp Fribourg, Clin Oncol, Villar Sur Glane, Switzerland
[11] Ctr Hosp Univ Vaudois CHUV, Dept Oncol, Lausanne, Switzerland
[12] Kantonsspital St Gallen, Dept Med Oncol & Hematol, St Gallen, Switzerland
[13] Cantonal Hosp Baden, Ctr Oncol Hematol, Baden, Switzerland
[14] Cantonal Hosp Baden, Ctr Comprehens Canc, Baden, Switzerland
[15] Univ Hosp Basel, Dept Med Oncol, Basel, Switzerland
[16] Univ Zurich, Univ Zurich Hosp, Dept Thorac Surg, Zurich, Switzerland
[17] Hop Valais, Clin Thorac Surg, Sion, Switzerland
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1282
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1223P
引用
收藏
页码：S786 / S786
页数：1
相关论文
共 50 条
  • [41] PET Radiomics Model Based on Multi-Centre Imaging Data of SAKK 16/00 to Predict Event-Free Survival in Locally Advanced Non-Small Cell Lung Cancer
    Oliveira, C.
    Amstutz, F.
    Vuong, D.
    Bogowicz, M.
    Denzler, S.
    Foerster, R.
    Alexandros, X.
    Pless, M.
    Thierstein, S.
    Peters, S.
    Unkelbach, J.
    Basler, L.
    Guckenberger, M.
    Tanadini-Lang, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E141 - E142
  • [42] Expression of p16INK4a/p16α and p19ARF/p16β is frequently altered in non-small cell lung cancer and correlates with p53 overexpression
    Vonlanthen, S
    Heighway, J
    Tschan, MP
    Borner, MM
    Altermatt, HJ
    Kappeler, A
    Tobler, A
    Fey, MF
    Thatcher, N
    Yarbrough, WG
    Betticher, D
    ONCOGENE, 1998, 17 (21) : 2779 - 2785
  • [43] Expression of p16INK4a/p16α and p19ARF/p16β is frequently altered in non-small cell lung cancer and correlates with p53 overexpression
    Silvia Vonlanthen
    Jim Heighway
    Mario P Tschan
    Markus M Borner
    Hans J Altermatt
    Andreas Kappeler
    Andreas Tobler
    Martin F Fey
    Nick Thatcher
    Wendell G Yarbrough
    Daniel C Betticher
    Oncogene, 1998, 17 : 2779 - 2785
  • [44] The Promoter Hypermethylation of DAPK Gene and p16 Gene in Non-small Cell Lung Cancer Patients
    Zheng, Shi-ying
    Jiang, Dong
    Ge, Jin-feng
    PROCEEDINGS OF THE 2009 2ND INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING AND INFORMATICS, VOLS 1-4, 2009, : 896 - 903
  • [45] Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials
    Xiao, Zheng
    Wang, Cheng-qiong
    Zhou, Ming-hua
    Li, Na-na
    Liu, Shi-yu
    He, Yue-juan
    Wang, Yu-zhi
    Feng, Ji-hong
    Yao, Xin-sheng
    Chen, Ling
    Ma, Bin
    Yu, Song
    Zeng, Xian-tao
    Li, Cheng-wen
    Ding, Jie
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 61 : 363 - 375
  • [46] lncRNA SLC16A1-AS1 as a novel prognostic biomarker in non-small cell lung cancer
    Liu, Hong Yue
    Lu, Sheng Rong
    Guo, Zi Han
    Zhang, Zhi Sheng
    Ye, Xuan
    Du, Qiong
    Li, Huan
    Wu, Qiang
    Yu, Bo
    Zhai, Qing
    Liu, Jin Long
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (01) : 52 - 59
  • [47] Induction of apoptosis in non-small cell lung cancer cells by p16(INK4)
    Kataoka, M
    Roth, JA
    Cristiano, RJ
    CANCER GENE THERAPY, 1996, 3 (06) : P111 - P111
  • [48] Multimodal Treatment in Operable Stage III Non-Small Cell Lung Cancer using the New TNM Staging Classification Version 8: Long Term Results of a Pooled Analysis of three SAKK trials
    Fruh, M.
    Betticher, D. C.
    Stupp, R.
    Xyrafas, A.
    Peters, S.
    Ris, H. B.
    Ochsenbein, A.
    Schmid, R.
    Stahel, R. A.
    Weder, W.
    Guckenberger, M.
    Rothschild, S.
    Lardinois, D.
    Mach, N.
    Mark, M.
    Gautschi, O.
    Thierstein, S.
    Rudolf, Biaggi C.
    Pless, M.
    SWISS MEDICAL WEEKLY, 2018, 148 : 18S - 18S
  • [49] Exon-16-skipping ERBB2 (ERBB2ΔEx16) as a novel resistance mechanism against EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC).
    Zhao, Xin
    Jin, Linling
    Yu, Man
    Ou, Qiuxiang
    Bao, Hua
    Wu, Xue
    Shao, Yang
    Fan, Min
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] The influence of sex and histology on outcomes in non-small cell lung cancer: a pooled analysis of 5 randomized trials
    Wheatley-Price, Paul
    Blackball, Fiona
    Lee, Siow-Ming
    Ma, Clement
    Ashcroft, Linda
    Jitlal, Mark
    Qian Wendi
    Hackshaw, Allan
    Rudd, Robin
    Booton, Richard
    Danson, Sarah
    Lorigan, Paul
    Thatcher, Nick
    Shepherd, Frances A.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S286 - S287
12345